These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16760630)

  • 41. The Role of Testosterone in the Elderly: What Do We Know?
    Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hormone replacement Up-to-date. The effects of androgen replacement therapy on brain function].
    Kumano H
    Clin Calcium; 2007 Sep; 17(9):1378-83. PubMed ID: 17767027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
    Morgunov LIu; Vertkin AL; Pushkar' DIu
    Urologiia; 2007; (5):49-51. PubMed ID: 18254226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.
    Siddique H; Smith JC; Corrall RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):143-5. PubMed ID: 14678301
    [No Abstract]   [Full Text] [Related]  

  • 45. [Kallmann syndrome--a form of hypogonadotropic hypogonadism].
    Hefner J; Csef H; Seufert J
    Dtsch Med Wochenschr; 2009 May; 134(22):1157-60. PubMed ID: 19603380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone and men's quality of life.
    Moncada I
    Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testosterone deficiency and replacement in older men.
    Bremner WJ
    N Engl J Med; 2010 Jul; 363(2):189-91. PubMed ID: 20647215
    [No Abstract]   [Full Text] [Related]  

  • 49. Central serous chorioretinopathy associated with testosterone therapy.
    Ahad MA; Chua CN; Evans NM
    Eye (Lond); 2006 Apr; 20(4):503-5. PubMed ID: 15846380
    [No Abstract]   [Full Text] [Related]  

  • 50. Reversible aquagenic pruritus associated with testosterone-induced erythrocytosis.
    Liu M; Shinkai K
    J Am Acad Dermatol; 2014 Jun; 70(6):e139-40. PubMed ID: 24831338
    [No Abstract]   [Full Text] [Related]  

  • 51. Testosterone deficiency: which patients should you screen and treat?
    Sadovsky R; Dhindsa S; Margo K
    J Fam Pract; 2007 May; 56(5 Suppl Testosterone):S1-20; quiz S21-3. PubMed ID: 17475159
    [No Abstract]   [Full Text] [Related]  

  • 52. Case report: treatment of androgen deficiency in the aging male.
    Hernandez A; Baum N
    Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone replacement therapy and cardiovascular risk factors modification.
    Chahla EJ; Hayek ME; Morley JE
    Aging Male; 2011 Jun; 14(2):83-90. PubMed ID: 21539436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risks of testosterone replacement.
    Redmond G
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15131838
    [No Abstract]   [Full Text] [Related]  

  • 55. Testosterone replacement therapy: is it worth the risk?
    Zurlinden J
    Nurs Spectr (Wash D C); 1999 Jun; 9(12):15-6. PubMed ID: 10562231
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hormone replacement Up-to-date. Clinical practice of androgen replacement therapy].
    Kawa G; Matsuda T
    Clin Calcium; 2007 Sep; 17(9):1414-8. PubMed ID: 17767032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone replacement therapy for the primary care physician.
    Casey RW; Barkin J
    Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.
    Hwang K; Miner M
    Asian J Androl; 2015; 17(2):187-91. PubMed ID: 25652628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.